Accident Compensation Corp Has $2.28 Million Holdings in CVS Health Corp (CVS)

Accident Compensation Corp lessened its stake in shares of CVS Health Corp (NYSE:CVS) by 18.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,078 shares of the pharmacy operator’s stock after selling 6,467 shares during the period. Accident Compensation Corp’s holdings in CVS Health were worth $2,283,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Eagle Ridge Investment Management boosted its holdings in shares of CVS Health by 1.4% during the 2nd quarter. Eagle Ridge Investment Management now owns 179,847 shares of the pharmacy operator’s stock valued at $14,232,000 after purchasing an additional 2,479 shares during the last quarter. NewFocus Financial Group LLC bought a new position in shares of CVS Health during the 2nd quarter valued at about $2,552,000. Palladium Partners LLC lifted its holdings in shares of CVS Health by 14.8% in the 2nd quarter. Palladium Partners LLC now owns 80,422 shares of the pharmacy operator’s stock valued at $6,471,000 after acquiring an additional 10,363 shares during the last quarter. Beach Investment Management LLC. bought a new position in shares of CVS Health in the 2nd quarter valued at about $2,224,000. Finally, Endurance Wealth Management Inc. lifted its holdings in shares of CVS Health by 7.6% in the 2nd quarter. Endurance Wealth Management Inc. now owns 115,270 shares of the pharmacy operator’s stock valued at $9,275,000 after acquiring an additional 8,160 shares during the last quarter. 80.81% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently commented on CVS. Needham & Company LLC set a $98.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Friday, February 9th. ValuEngine downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Leerink Swann set a $85.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Friday, February 9th. Robert W. Baird reaffirmed a “hold” rating and issued a $77.00 price target on shares of CVS Health in a report on Friday, October 27th. Finally, Mizuho set a $90.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $87.82.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the firm’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the transaction, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at $1,166,700. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.61% of the company’s stock.

Shares of CVS Health Corp (CVS) opened at $70.11 on Wednesday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The stock has a market cap of $71,020.00, a PE ratio of 11.88, a price-to-earnings-growth ratio of 1.18 and a beta of 0.92. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.00.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.88 by $0.04. The business had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 earnings per share. equities analysts forecast that CVS Health Corp will post 6.44 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.85%. The ex-dividend date of this dividend was Tuesday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.

ILLEGAL ACTIVITY WARNING: “Accident Compensation Corp Has $2.28 Million Holdings in CVS Health Corp (CVS)” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/14/cvs-health-corp-cvs-stake-lowered-by-accident-compensation-corp.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply